MedPath

Comparison between Hyperbaric Ropivacaine (0.75%) and Hyperbaric Bupivacaine (0.5%) given intrathecally for ACL tear repair surgeries.

Phase 2
Conditions
Health Condition 1: M232- Derangement of meniscus due to oldtear or injury
Registration Number
CTRI/2022/06/043332
Lead Sponsor
IGIMS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients consent

Patients aged between 30-60 years of both the sexes.

Patients with ASA Grade 1 2 & 3.

Patients undergoing elective knee arthroscopy surgery under spinal anaesthesia.

Exclusion Criteria

Patients refusal.

Patients with ASA Grade 4 or higher.

Patients with known congenital spine or limb deformity.

Patients on Psychotropic drugs or history of drug allergies

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath